• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模型的磁化传递成像标记物用于对亨廷顿舞蹈病患者及无症状基因携带者进行特征描述。

Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington's Disease.

作者信息

Wiest Roland, Burgunder Jean-Marc, Kiefer Claus

机构信息

Support Center of Advanced Neuroimaging (SCAN), Institute for Diagnostic and Interventional Neuroradiology, University of Bern, Inselspital, University Hospital, Bern, Switzerland.

Neurology, University of Bern, Inselspital, University Hospital, Bern, Switzerland.

出版信息

Front Neurol. 2017 Sep 6;8:465. doi: 10.3389/fneur.2017.00465. eCollection 2017.

DOI:10.3389/fneur.2017.00465
PMID:28932207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5592228/
Abstract

BACKGROUND AND PURPOSE

Huntington's disease (HD) is a chronic progressive neurodegenerative disorder with a long presymptomatic period that opens a window for potential therapies aimed at neuroprotection. Neuroimaging offers the potential to monitor disease-related progression of the disease burden (DB) using model-based magnetization transfer imaging.

MATERIALS AND METHODS

We have conducted a cross-sectional study to stratify healthy age-matched controls, premanifest and symptomatic HD patients ( = 30) according to their macromolecular depositions in the caudate nucleus. We employed a binary spin-bath magnetization transfer (MT) method for a quantitative description of macromolecule deposits and interactions with their adjacent environment.

RESULTS

A region-of-interest based fuzzy clustering analysis identified representative clusters for several stages of the disease course related to its progression: one cluster represented subjects with a high DB <268 that encompassed all symptomatic HD patients and one presymptomatic gene carrier. The next cluster represented the presymptomatic gene carriers with a very low DB >230 and healthy controls. Three further clusters represented transition zones between both DB levels (230-268) consisting of presymptomatic carriers with DB values increasing with decreasing distance from the cluster that indicated low DB and healthy age-matched controls.

CONCLUSION

The proposed binary spin-bath MT method offers the potential to monitor DB and progression in HD. The method may augment qualitative MT techniques since it depicts tissue changes related to interactions between macromolecules and protons in disease specific brain regions that follow the neurodegenerative process.

摘要

背景与目的

亨廷顿舞蹈症(HD)是一种慢性进行性神经退行性疾病,有较长的症状前期,这为旨在进行神经保护的潜在治疗打开了一扇窗。神经成像技术利用基于模型的磁化传递成像,有潜力监测疾病负担(DB)的疾病相关进展。

材料与方法

我们进行了一项横断面研究,根据尾状核中的大分子沉积情况,对年龄匹配的健康对照、症状前期和症状性HD患者(n = 30)进行分层。我们采用二元自旋浴磁化传递(MT)方法对大分子沉积物及其与相邻环境的相互作用进行定量描述。

结果

基于感兴趣区域的模糊聚类分析确定了与疾病进展相关的几个病程阶段的代表性聚类:一个聚类代表DB值高<268的受试者,包括所有症状性HD患者和一名症状前期基因携带者。下一个聚类代表DB值非常低>230的症状前期基因携带者和健康对照。另外三个聚类代表两个DB水平(230 - 268)之间的过渡区,由DB值随着与表示低DB的聚类和年龄匹配的健康对照的距离减小而增加的症状前期携带者组成。

结论

所提出的二元自旋浴MT方法有潜力监测HD中的DB和疾病进展。该方法可能增强定性MT技术,因为它描绘了与疾病特定脑区中大分子和质子之间相互作用相关的组织变化,这些变化遵循神经退行性过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/5592228/8677784dae55/fneur-08-00465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/5592228/05b66b8e36c1/fneur-08-00465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/5592228/43bea0e34018/fneur-08-00465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/5592228/8677784dae55/fneur-08-00465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/5592228/05b66b8e36c1/fneur-08-00465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/5592228/43bea0e34018/fneur-08-00465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0e/5592228/8677784dae55/fneur-08-00465-g003.jpg

相似文献

1
Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington's Disease.基于模型的磁化传递成像标记物用于对亨廷顿舞蹈病患者及无症状基因携带者进行特征描述。
Front Neurol. 2017 Sep 6;8:465. doi: 10.3389/fneur.2017.00465. eCollection 2017.
2
Molecular Imaging Markers to Track Huntington's Disease Pathology.用于追踪亨廷顿舞蹈病病理的分子成像标记物
Front Neurol. 2017 Jan 30;8:11. doi: 10.3389/fneur.2017.00011. eCollection 2017.
3
White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.临床前期和早期亨廷顿舞蹈症患者的白质完整性与尾状核萎缩及疾病进展相关。
Cortex. 2014 Mar;52:98-112. doi: 10.1016/j.cortex.2013.11.009. Epub 2013 Dec 6.
4
Longitudinal metabolite changes in Huntington's disease during disease onset.亨廷顿舞蹈病发病过程中的纵向代谢物变化
J Huntingtons Dis. 2014;3(4):377-86. doi: 10.3233/JHD-140117.
5
Elevated brain iron is independent from atrophy in Huntington's Disease.亨廷顿病患者脑铁含量升高与脑萎缩无关。
Neuroimage. 2012 Jul 2;61(3):558-64. doi: 10.1016/j.neuroimage.2012.03.056. Epub 2012 Mar 28.
6
Structural Magnetic Resonance Imaging in Huntington's Disease.结构磁共振成像在亨廷顿病中的应用。
Int Rev Neurobiol. 2018;142:335-380. doi: 10.1016/bs.irn.2018.09.006. Epub 2018 Oct 8.
7
Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.多模态影像生物标志物在未显症和早期亨廷顿病中的应用:IMAGE-HD 研究 30 个月数据。
Br J Psychiatry. 2016 Jun;208(6):571-8. doi: 10.1192/bjp.bp.114.156588. Epub 2015 Dec 17.
8
Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.亨廷顿病患者脑组织钠离子浓度增加——4T 下的钠成像研究。
Neuroimage. 2012 Oct 15;63(1):517-24. doi: 10.1016/j.neuroimage.2012.07.009. Epub 2012 Jul 14.
9
Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.无症状基因携带者和亨廷顿病患者的纹状体葡萄糖代谢及多巴胺D2受体结合情况
Brain. 1996 Dec;119 ( Pt 6):2085-95. doi: 10.1093/brain/119.6.2085.
10
Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.尾状核头部横截面积分析在亨廷顿病中的应用。
Eur Neurol. 2019;81(1-2):13-18. doi: 10.1159/000499909. Epub 2019 Apr 23.

本文引用的文献

1
Myelin Breakdown in Human Huntington's Disease: Multi-Modal Evidence from Diffusion MRI and Quantitative Magnetization Transfer.人类亨廷顿舞蹈病中的髓鞘破坏:来自弥散 MRI 和定量磁化传递的多模态证据。
Neuroscience. 2019 Apr 1;403:79-92. doi: 10.1016/j.neuroscience.2017.05.042. Epub 2017 Jun 1.
2
A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers.一项关于磁共振波谱亨廷顿舞蹈病生物标志物的纵向研究。
Mov Disord. 2015 Mar;30(3):393-401. doi: 10.1002/mds.26118. Epub 2015 Feb 18.
3
Diagnostic criteria for Huntington's disease based on natural history.
基于自然病史的亨廷顿舞蹈症诊断标准。
Mov Disord. 2014 Sep 15;29(11):1335-41. doi: 10.1002/mds.26011. Epub 2014 Aug 27.
4
White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.临床前期和早期亨廷顿舞蹈症患者的白质完整性与尾状核萎缩及疾病进展相关。
Cortex. 2014 Mar;52:98-112. doi: 10.1016/j.cortex.2013.11.009. Epub 2013 Dec 6.
5
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.TRACK-HD 研究中在无症状和早期亨廷顿病中表型进展和疾病发作的预测因素:36 个月观察性数据的分析。
Lancet Neurol. 2013 Jul;12(7):637-49. doi: 10.1016/S1474-4422(13)70088-7. Epub 2013 May 9.
6
Recent advances in the management of choreas.近期舞蹈病治疗的进展。
Ther Adv Neurol Disord. 2013 Mar;6(2):117-27. doi: 10.1177/1756285612471700.
7
Translational research in Huntington's disease: opening up for disease modifying treatment.亨廷顿病的转化研究:为疾病修饰治疗开辟道路。
Transl Neurodegener. 2013 Jan 25;2(1):2. doi: 10.1186/2047-9158-2-2.
8
Classification of mild cognitive impairment and Alzheimer disease using model-based MR and magnetization transfer imaging.基于模型的磁共振和磁化传递成像在轻度认知障碍和阿尔茨海默病分类中的应用。
AJNR Am J Neuroradiol. 2013 Apr;34(4):740-6. doi: 10.3174/ajnr.A3307. Epub 2012 Oct 11.
9
Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up.磁敏感转移成像在隐匿性和显性亨廷顿病中的应用:2 年随访。
AJNR Am J Neuroradiol. 2013 Feb;34(2):317-22. doi: 10.3174/ajnr.A3303. Epub 2012 Aug 23.
10
Huntington's disease.亨廷顿病。
Curr Opin Neurol. 2012 Aug;25(4):491-8. doi: 10.1097/WCO.0b013e3283550c97.